Mohamed El‐Sheemy

865 total citations
14 papers, 551 citations indexed

About

Mohamed El‐Sheemy is a scholar working on Oncology, Cancer Research and Epidemiology. According to data from OpenAlex, Mohamed El‐Sheemy has authored 14 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Cancer Research and 3 papers in Epidemiology. Recurrent topics in Mohamed El‐Sheemy's work include Cervical Cancer and HPV Research (3 papers), Global Cancer Incidence and Screening (2 papers) and Ovarian cancer diagnosis and treatment (2 papers). Mohamed El‐Sheemy is often cited by papers focused on Cervical Cancer and HPV Research (3 papers), Global Cancer Incidence and Screening (2 papers) and Ovarian cancer diagnosis and treatment (2 papers). Mohamed El‐Sheemy collaborates with scholars based in United Kingdom, Saudi Arabia and Egypt. Mohamed El‐Sheemy's co-authors include Issam Hussain, Ibrahim Alghamdi, Oleg Eremin, Mansour Alghamdi, Shaia Almalki, Jennifer Eremin, Mohammed Alghamdi, D Valerio, David W. Clark and Adrian Robins and has published in prestigious journals such as European Journal of Cancer, Annals of Surgical Oncology and BMC Cancer.

In The Last Decade

Mohamed El‐Sheemy

14 papers receiving 544 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohamed El‐Sheemy United Kingdom 10 224 122 118 108 92 14 551
Teena Bhatla United States 16 261 1.2× 281 2.3× 81 0.7× 52 0.5× 68 0.7× 35 788
Riad El Fakih Saudi Arabia 13 218 1.0× 110 0.9× 87 0.7× 122 1.1× 21 0.2× 76 672
Risa Ebina‐Shibuya Japan 11 108 0.5× 163 1.3× 323 2.7× 76 0.7× 67 0.7× 25 679
Qing Cheng China 9 169 0.8× 230 1.9× 94 0.8× 76 0.7× 36 0.4× 23 722
Yara Abdou United States 13 415 1.9× 90 0.7× 121 1.0× 99 0.9× 101 1.1× 64 626
Laura Vidal Spain 10 231 1.0× 135 1.1× 79 0.7× 59 0.5× 40 0.4× 23 465
Arnold Simons Netherlands 19 165 0.7× 219 1.8× 62 0.5× 21 0.2× 36 0.4× 39 1.1k
Abdellatif Benider Morocco 16 498 2.2× 134 1.1× 52 0.4× 41 0.4× 130 1.4× 102 906
John T. Cole United States 10 189 0.8× 110 0.9× 62 0.5× 33 0.3× 86 0.9× 25 613
Xuejun Xu China 8 147 0.7× 130 1.1× 36 0.3× 108 1.0× 48 0.5× 12 506

Countries citing papers authored by Mohamed El‐Sheemy

Since Specialization
Citations

This map shows the geographic impact of Mohamed El‐Sheemy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohamed El‐Sheemy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohamed El‐Sheemy more than expected).

Fields of papers citing papers by Mohamed El‐Sheemy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohamed El‐Sheemy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohamed El‐Sheemy. The network helps show where Mohamed El‐Sheemy may publish in the future.

Co-authorship network of co-authors of Mohamed El‐Sheemy

This figure shows the co-authorship network connecting the top 25 collaborators of Mohamed El‐Sheemy. A scholar is included among the top collaborators of Mohamed El‐Sheemy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohamed El‐Sheemy. Mohamed El‐Sheemy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Hussain, Issam, et al.. (2019). Stem Cell Factor Antibody: Effective Manipulation of Antihormonal Therapy in Resistant Human Breast Cancer In Vitro. Journal of Drug Delivery. 9(4). 608–612. 1 indexed citations
2.
Hussein, Ahmed A., et al.. (2017). Outcome of pediatric renal transplantation in urological versus non-urological causes of end stage renal disease: Does it matter?. Journal of Pediatric Urology. 14(2). 166.e1–166.e7. 12 indexed citations
3.
El‐Sheemy, Mohamed, et al.. (2015). The role of Nanog expression in tamoxifen-resistant breast cancer cells. OncoTargets and Therapy. 8. 1327–1327. 20 indexed citations
4.
5.
Alghamdi, Ibrahim, et al.. (2014). The pattern of Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive epidemiological analysis of data from the Saudi Ministry of Health. International Journal of General Medicine. 7. 417–417. 169 indexed citations
6.
Alghamdi, Ibrahim, et al.. (2014). Incidence rate of ovarian cancer cases in Saudi Arabia: an observational descriptive epidemiological analysis of data from Saudi Cancer Registry 2001–2008. International Journal of Women s Health. 6. 639–639. 10 indexed citations
7.
8.
9.
Alghamdi, Ibrahim, Issam Hussain, Mohamed El‐Sheemy, & Mohammed Alghamdi. (2013). The incidence rate of female breast cancer in Saudi Arabia: an observational descriptive epidemiological analysis of data from Saudi Cancer Registry 2001–2008. Breast Cancer Targets and Therapy. 5. 103–103. 62 indexed citations
10.
Hussain, Issam, et al.. (2012). New approach to isolate mesenchymal stem cell (MSC) from human umbilical cord blood. Cell Biology International. 36(7). 595–600. 18 indexed citations
11.
12.
Chuthapisith, Suebwong, Gerard Cowley, Jennifer Eremin, et al.. (2009). Annexins in human breast cancer: Possible predictors of pathological response to neoadjuvant chemotherapy. European Journal of Cancer. 45(7). 1274–1281. 69 indexed citations
13.
Eremin, Jennifer, et al.. (2008). Management of the Axilla in Women With Breast Cancer: Current Clinical Practice and a New Selective Targeted Approach. Annals of Surgical Oncology. 15(5). 1282–1296. 53 indexed citations
14.
Robins, Adrian, et al.. (2004). Dendritic cells are dysfunctional in patients with operable breast cancer. Cancer Immunology Immunotherapy. 53(6). 510–518. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Teena Bhatla Breakdown of academic impact, for papers by Riad El Fakih Breakdown of academic impact, for papers by Risa Ebina‐Shibuya Breakdown of academic impact, for papers by Qing Cheng Breakdown of academic impact, for papers by Yara Abdou Breakdown of academic impact, for papers by Laura Vidal Breakdown of academic impact, for papers by Arnold Simons Breakdown of academic impact, for papers by Abdellatif Benider Breakdown of academic impact, for papers by John T. Cole Breakdown of academic impact, for papers by Xuejun Xu
Rankless by CCL
2026